Some basic researches on immunological biomarkers and microenvironments, e.g., studies of intratumoral lymphoid infiltrates with intratumoral PD-L1 expression and the interferon-gamma pathway in tumor tissue, show that these factors can predict the response to immune checkpoint inhibitors [17, 18]. Here, IFNG is linked to neoplasm.